TEMPE, Arizona, January 23 /PRNewswire/ --

Circuit Research Labs, Inc. (OTC Bulletin Board: CRLI), parent company of Orban/CRL, a worldwide leader in audio processing for AM, FM, TV, and Internet broadcasting today announced major changes to its European operations.

With a new central processing center for Europe effective February 15, 2008, Orban Europe will now be fully responsible for all sales, orders, repairs and accounting in the European Union. Additionally, the company will begin full production and manufacturing of all Orban products in Germany later this year.

LONDON, January 23 /PRNewswire/ --

FocusVision, the world's leading provider of video transmission, recording and analytical tools for market research, today announced the expansion of their lower-priced fixed-camera "VideoStreaming" solution in Europe. With this offering, FocusVision is able to deliver a choice of service at a lower price point, while reaffirming its commitment to providing clients with the industry's most reliable video transmission services.

EDINBURGH, Scotland, January 23 /PRNewswire/ --

- Aircraft Medical's Success at European Patent Hearing is Confirmed by Verathon's Appeal.

The European Patent Office (EPO) has found Verathon's European Patent (the '131' patent) not valid as granted. In a ruling on Oct 16, 2007, a narrower version of the patent was upheld. In a PR twist however, Verathon issued a press statement into wide distribution announcing the EPO ruling as a success, despite the fact that the ruling severely weakened its patent.

Verathon has now appealed the EPO's October 2007 ruling. This appeal very effectively demonstrates that the EPO decision was in fact not favourable to Verathon.

TARRYTOWN, New York, January 23 /PRNewswire/ --

EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today provided updates on the regulatory and clinical status of Ceplene(TM) (histamine dihydrochloride) and EpiCept(TM) NP-1 Cream.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

EpiCept announced today that its Marketing Authorization Application (MAA) seeking marketing approval for Ceplene in the European Union has advanced to the next important step. The Company has submitted full written responses to the Day 180 List of Outstanding Issues to the Committee for Human Medicinal Products (CHMP). With this response, EpiCept believes it has now addressed all outstanding issues related to the MAA.

BERLIN, January 22 /PRNewswire/ --

- Company expands the impact of Partners in Learning program over the next five years, reaching up to three times as many students, teachers and schools.

PALO ALTO, California, January 22 /PRNewswire/ --

TONIC, a Silicon Valley company offering exclusive, limited edition merchandise and services benefiting global causes, today announces its Board of Creators.

TONIC is defined as anything invigorating, mentally, morally or physically, which embodies the spirit of what the company is trying to accomplish. The company's mission is to sell products online that look attractive, feel great and most importantly, contribute to causes and people who need it most. Consumers have enthusiastically greeted TONIC's first run of limited-edition tees since their introduction in December.